AUD 0.02
(-8.7%)
Year | Inventory | Inventory Growth |
---|---|---|
2024 | -987.41 Thousand AUD | 0.0% |
2023 | - AUD | -100.0% |
2022 | 1.00 AUD | 100.02% |
2021 | -6347.00 AUD | 0.0% |
Year | Inventory | Inventory Growth |
---|---|---|
2024 Q1 | 1.00 AUD | 0.0% |
2024 Q2 | 1.00 AUD | 0.0% |
2024 Q3 | - AUD | -100.0% |
2024 Q4 | -987.41 Thousand AUD | 0.0% |
2024 FY | - AUD | 0.0% |
2023 Q4 | - AUD | 0.0% |
2023 FY | - AUD | -100.0% |
2023 Q3 | - AUD | 0.0% |
2023 Q2 | - AUD | 0.0% |
2023 Q1 | - AUD | -100.0% |
2022 Q4 | 1.00 AUD | 0.0% |
2022 Q3 | 1.00 AUD | 0.0% |
2022 Q2 | - AUD | 0.0% |
2022 Q1 | - AUD | 0.0% |
2022 FY | 1.00 AUD | 100.02% |
2021 FY | -6347.00 AUD | 0.0% |
Name | Inventory | Inventory Difference |
---|---|---|
EZZ Life Science Holdings Limited | 1.4 Million AUD | 170.469% |
Anatara Lifesciences Ltd | -671.09 Thousand AUD | -47.135% |
Zelira Therapeutics Limited | 1.25 Million AUD | 178.847% |
Biome Australia Limited | 1.88 Million AUD | 152.283% |
Patrys Limited | - AUD | Infinity% |
Orthocell Limited | 1.17 Million AUD | 183.918% |
Imugene Limited | - AUD | Infinity% |
Noxopharm Limited | -2.35 Million AUD | 58.147% |
PYC Therapeutics Limited | -17.99 Million AUD | 94.513% |
Chimeric Therapeutics Limited | - AUD | Infinity% |
Prescient Therapeutics Limited | - AUD | Infinity% |
Proteomics International Laboratories Limited | - AUD | Infinity% |
Cynata Therapeutics Limited | 108.2 Thousand AUD | 1012.548% |
CSL Limited | 8.93 Billion AUD | 100.011% |
Arovella Therapeutics Limited | - AUD | Infinity% |
Bio-Gene Technology Limited | - AUD | Infinity% |
Clinuvel Pharmaceuticals Limited | 10.62 Million AUD | 109.292% |
Starpharma Holdings Limited | 2.4 Million AUD | 141.006% |
Nanollose Limited | - AUD | Infinity% |
Memphasys Limited | 164.76 Thousand AUD | 699.3% |
Invex Therapeutics Ltd | -94.98 Thousand AUD | -939.568% |
NeuroScientific Biopharmaceuticals Limited | - AUD | Infinity% |
Amplia Therapeutics Limited | - AUD | Infinity% |
Botanix Pharmaceuticals Limited | 1.2 Million AUD | 181.647% |
Island Pharmaceuticals Limited | -877.24 Thousand AUD | -12.559% |
Race Oncology Limited | 16.4 Thousand AUD | 6120.444% |
Nyrada Inc. | - AUD | Infinity% |
Telix Pharmaceuticals Limited | 17.31 Million AUD | 105.704% |
Dimerix Limited | - AUD | Infinity% |
PharmAust Limited | - AUD | Infinity% |
Immutep Limited | 2.00 AUD | 49370750.0% |
Clarity Pharmaceuticals Ltd | - AUD | Infinity% |
Alterity Therapeutics Limited | 1.00 AUD | 98741400.0% |
BTC Health Limited | - AUD | Infinity% |
Acrux Limited | 147 Thousand AUD | 771.71% |
Neuren Pharmaceuticals Limited | - AUD | Infinity% |
Biotron Limited | - AUD | Infinity% |
Tissue Repair Ltd | 214.72 Thousand AUD | 559.856% |
AdAlta Limited | -1.67 Million AUD | 41.209% |
Hexima Limited | - AUD | Infinity% |
AnteoTech Limited | 221.85 Thousand AUD | 545.067% |
Paradigm Biopharmaceuticals Limited | - AUD | Infinity% |
Recce Pharmaceuticals Ltd | - AUD | Infinity% |
Avecho Biotechnology Limited | 97.11 Thousand AUD | 1116.725% |
Actinogen Medical Limited | 108.82 Thousand AUD | 1007.307% |
Immuron Limited | 1.58 Million AUD | 162.313% |
Argenica Therapeutics Limited | - AUD | Infinity% |